2
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Colorectal Neoplasms
3
Glioblastoma
2
Vulvar Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplastic Cells, Circulating
1
Neoplasm, Residual
1
Muscle Invasive Bladder Urothelial Carcinoma
1
Melanoma
1
Locally Advanced Rectal Carcinoma
1
Hypoxia
1
Gliosarcoma
1
Glioma
1
Genetic Diseases, Inborn
1
Esophageal Neoplasms
1
Circulating Tumor DNA
1
Carcinoma, Non-Small-Cell Lung
1
Biliary Tract Neoplasms
1
Astrocytoma
1
Interventions
3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol
6
pimonidazole
4
fluoroazomycin arabinoside
4
TH 302
4
Radiotherapy
4
Propofol
3
Injections
3
Positron Emission Tomography Computed Tomography
2
Drug Therapy
2
Blood Specimen Collection
2
Bacterial Load
2
pomalidomide
1
pembrolizumab
1
inositol trispyrophosphate
1
gadobutrol
1
fluoromisonidazole
1
fludarabine
1
alovudine
1
Tirapazamine
1
Thoracotomy
1
Thoracic Surgery, Video-Assisted
1
Temozolomide
1
Surgical Procedures, Operative
1
Sodium Chloride
1
Sevoflurane
1
Saline Solution
1
Pancreaticoduodenectomy
1
Paclitaxel
1
Oxygen
1
Nitroglycerin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hypoxia
×
Circulating Tumor DNA
×
Clear all
NCT05702619
2023-01-27
HYPROGEN
The Christie NHS Foundation Trust
Unknown
60 enrolled